Introduction
Introduction Statistics Contact Development Disclaimer Help
Return Create A Forum - Home
---------------------------------------------------------
MS Speaks
https://msspeaks.createaforum.com
---------------------------------------------------------
*****************************************************
Return to: ZEPOSIA (ozanimod)
*****************************************************
#Post#: 2856--------------------------------------------------
FDA approves ozanimod (Zeposia), oral treatment for MS, includin
g active SPMS
By: agate Date: March 26, 2020, 10:18 am
---------------------------------------------------------
Another MS drug is rolled out--with another name that isn't easy
to pronounce. Is it ze-PO-si-a or ze-po-SI-a?
From Multiple Sclerosis News Today (March 26, 2020):
https://multiplesclerosisnewstoday.com/news-posts/2020/03/26/fda-approves-zepos…
#Post#: 2857--------------------------------------------------
Zeposia release delayed because of pandemic
By: agate Date: March 28, 2020, 12:34 am
---------------------------------------------------------
Zeposia won't be available just now after all because of the
COVID-19 pandemic, according to FiercePharma (March 27, 2020):
https://www.fiercepharma.com/pharma/bristol-myers-investors-breathe-a-sigh-reli…
#Post#: 2923--------------------------------------------------
Press release about availability of Zeposia
By: agate Date: June 2, 2020, 11:10 am
---------------------------------------------------------
A press release (June 1, 2020) about the availability of Zeposia
(ozanimod):
https://news.bms.com/press-release/corporatefinancial-news/bristol-myers-squibb…
#Post#: 3013--------------------------------------------------
Zeposia (ozanimod) preventing relapses in RMS patients after 3 y
ears according to trial data
By: agate Date: September 4, 2020, 12:32 am
---------------------------------------------------------
From Multiple Sclerosis News Today (September 3, 2020)--"Zeposia
still prevents relapses in relapsing multiple sclerosis patients
after 3 years, trial data show":
https://bit.ly/3jIzYP4
*****************************************************
You are viewing proxied material from gopher.createaforum.com. The copyright of proxied material belongs to its original authors. Any comments or complaints in relation to proxied material should be directed to the original authors of the content concerned. Please see the disclaimer for more details.